A novel role for an old target: CD45 for breast cancer immunotherapy

Breast cancer subtypes have not shown significant response to current immunomodulatory therapies. Although most subtypes are treatable, triple negative breast cancer (TNBC), an aggressive highly metastatic cancer, comprising 10–20% of breast cancers, remains an unmet medical need. New strategies are...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Main Authors: Raiter, Annat, Zlotnik, Oran, Lipovetsky, Julia, Mugami, Shany, Dar, Shira, Lubin, Ido, Sharon, Eran, Cohen, Cyrille J., Yerushalmi, Rinat
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8158046/
https://ncbi.nlm.nih.gov/pubmed/34104545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1929725
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares